Companies / Travere Therapeutics, Inc. / Activity
Activity — Travere Therapeutics, Inc.
13 moves.
Top impactInsider · CEO movesInsider · biggest buysInsider · biggest sellsInstitution · biggest movesInstitution · new positions
| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Feb 3, 2026 | Dube Eric M CEO | Sell | Common Stock | $2.13M | -66K -12.47% | 466,521 0.49% of shares | medium |
| Feb 20, 2026 | Dube Eric M CEO | Sell | Common Stock | $1.81M | -60K -12.17% | 432,886 0.46% of shares | medium |
| Jan 27, 2026 | Dube Eric M CEO | Sell | Common Stock | $1.56M | -52K -11.01% | 419,173 0.44% of shares | medium |
| Feb 3, 2026 | Dube Eric M CEO | Sell | Common Stock | $1.10M | -34K -7.21% | 432,886 0.46% of shares | medium |
| Feb 20, 2026 | Dube Eric M CEO | Exercise | Common Stock | $927.6K | +60K +13.86% | 492,886 0.52% of shares | low |
| Jan 27, 2026 | Dube Eric M CEO | Exercise | Common Stock | $801.8K | +52K +12.37% | 471,038 0.50% of shares | low |
| Jan 23, 2026 | Dube Eric M CEO | Sell | Common Stock | $244.2K | -8K -1.90% | 419,173 0.44% of shares | medium |
| Jan 23, 2026 | Dube Eric M CEO | Exercise | Common Stock | $125.8K | +8K +1.94% | 427,308 0.45% of shares | low |
| Jan 31, 2026 | Dube Eric M CEO | Grant | Common Stock | $0 | +114K +27.15% | 532,973 0.57% of shares | low |
| Feb 20, 2026 | Dube Eric M CEO | Exercise | Employee stock option (right to buy) | — | -60K -50.00% | 60,000 0.06% of shares | low |
| Jan 31, 2026 | Dube Eric M CEO | Grant | Employee stock option (right to buy) | — | +304K | 303,600 0.32% of shares | low |
| Jan 27, 2026 | Dube Eric M CEO | Exercise | Employee stock option (right to buy) | — | -52K -30.18% | 120,000 0.13% of shares | low |
| Jan 23, 2026 | Dube Eric M CEO | Exercise | Employee stock option (right to buy) | — | -8K -4.52% | 171,865 0.18% of shares | low |